Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1997 | Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions | Diccianni, M. B.; Batova, A.; Yu, J.; Vu, T.; Pullen, J.; Amylon, M.; Pollock, B.; Yu, A. L. | Leukemia Res 21, 549-558 | | | |
2012 | Structure-based design of cancer- targeting peptides for therapy and imaging | Wang, S. H.; Chen, I. J.; Chang, N. C.; Yu, A. L.; Wu, H. C.; Yu, H. M.; Chang, Y. J.; Lee, T. W.; Yu, J. C.; Lee, A. C-L; Yu, J. | NATURE BIOTECHNOLOGY | | | |
2012 | Surface markers in stem cells and cancer from the perspective of glycomic analysis | Cho, H. C.; Liao, C. H.; Yu, A. L.; Yu, J. | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 27(4):344 - 352 | | | |
2002 | The histone deacetylase inhibitor AN-9 has selective toxicity to drug-resistant primary leukemia and cancer cell lines | Batova, A.; Shao, L. E.; Diccianni, M. B.; Yu, A. L.; Tanaka, T.; Rephaeli, A.; Nudelman, A.; Yu, J. | Blood 100, 3319-3324 | | | |
2001 | Thioredoxin expression in primary childhood T-cell acute lymphoblastic leukemia and its therapeutic implications | Shao, L. E.; Diccianni, M. B.; Tanaka, T.; Yu, A. L.; Bessent, E.; Pullen, J.; Yu, J. | Cancer Res 61, 7333-7338 | | | |
2000 | Universal inactivation of both p16 and p15 but not downstream components is an essential event in pathogenesis of T-cell acute lymphoblastic leukemia | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L.; Yu, J.; Pullen, J.; Bowman, W. P.; Yu, A. L. | CLINICAL CANCER RESEARCH 6, 1219-1228 | | | |
1999 | Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro | Batova, A.; Diccianni, M. B.; Yu, J.; Carrera, C. J.; Bridgeman, L. J.; Kung, F. H.; Pullen, J.; Amylon, M. D.; Yu, A. L. | Cancer Research 59, 1492-1497 | | | |